This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schirmacher, P. Articles by Rogler, C. E. Search for Related Content PubMed PubMed Citation Articles by Schirmacher, P. Articles by Rogler, C. E.

American Journal of Pathology, Vol 139, 231-241, Copyright © 1991 by American Society for Investigative Pathology

REGULAR ARTICLES

Selective amplification of periportal transitional cells precedes formation of hepatocellular carcinoma in SV40 large tag transgenic mice

P Schirmacher, WA Held, D Yang, L Biempica and CE Rogler
Liver Research Center, Albert Einstein College of Medicine, Bronx, New York 10461.

In a major urinary protein (MUP)-promoter/simian virus 40 (SV40)Tag transgenic mouse line (MT-D2) the liver-directed, androgen-regulated transgene expression leads to synchronized pathology resulting in a stepwise progression to multiple hepatocellular carcinomas. SV40Tag- activated replication gives rise to two different preneoplastic alterations in hepatocytes, which are characterized in detail: 1) dysplasia and finally cell death in the original hepatocyte population and 2) amplification of periportal transitional hepatocytes leading to multifocal hyperplasia and hepatocellular carcinoma. Multifocal hyperplasia, most probably the equivalent of SV40Tag-immortalization, grows confluent and leads to hepatomegaly. SV40Tag-independent, secondary events are necessary for the tumor development from confluent hyperplasia. This allows further investigation of the steps involved in malignant transformation and progression during hepatocarcinogenesis in vivo.

This article has been cited by other articles:

				J.-S. Lee, J. W. Grisham, and S. S. Thorgeirsson Comparative functional genomics for identifying models of human cancer Carcinogenesis, June 1, 2005; 26(6): 1013 - 1020. [Abstract] [Full Text] [PDF]

				K. Breuhahn, S. Vreden, R. Haddad, S. Beckebaum, D. Stippel, P. Flemming, T. Nussbaum, W. H. Caselmann, B. B. Haab, and P. Schirmacher Molecular Profiling of Human Hepatocellular Carcinoma Defines Mutually Exclusive Interferon Regulation and Insulin-Like Growth Factor II Overexpression Cancer Res., September 1, 2004; 64(17): 6058 - 6064. [Abstract] [Full Text] [PDF]

				K. Nicholes, S. Guillet, E. Tomlinson, K. Hillan, B. Wright, G. D. Frantz, T. A. Pham, L. Dillard-Telm, S. P. Tsai, J.-P. Stephan, et al. A Mouse Model of Hepatocellular Carcinoma : Ectopic Expression of Fibroblast Growth Factor 19 in Skeletal Muscle of Transgenic Mice Am. J. Pathol., June 1, 2002; 160(6): 2295 - 2307. [Abstract] [Full Text] [PDF]

				N. G. Deane, M. A. Parker, R. Aramandla, L. Diehl, W.-J. Lee, M. K. Washington, L. B. Nanney, Y. Shyr, and R. D. Beauchamp Hepatocellular Carcinoma Results from Chronic Cyclin D1 Overexpression in Transgenic Mice Cancer Res., July 1, 2001; 61(14): 5389 - 5395. [Abstract] [Full Text] [PDF]

				M. Tateno, Y. Fukunishi, S. Komatsu, Y. Okazaki, J. Kawai, K. Shibata, M. Itoh, M. Muramatsu, W. A. Held, and Y. Hayashizaki Identification of a Novel Member of the Snail/Gfi-1 Repressor Family, mlt 1, Which Is Methylated and Silenced in Liver Tumors of SV40 T Antigen Transgenic Mice Cancer Res., February 1, 2001; 61(3): 1144 - 1153. [Abstract] [Full Text]

				P. A. FURTH, M. LI, and L. HENNIGHAUSEN Studying Development of Disease Through Temporally Controlled Gene Expression in the Salivary Gland Ann. N.Y. Acad. Sci., April 15, 1998; 842(1): 181 - 187. [Abstract] [Full Text] [PDF]